EN DE
Watch Kaneka Corporation for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Kaneka Corporation (KKA) fair value: what the stock is really worth

As of Nov 17, 2026: fair value (intrinsic value) of Kaneka Corporation stock €24.64, price €36.13, that is 31.8% below the price, quality 54 out of 100. Rating: overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials DE · Home Japan · ISIN JP3215800008

KC Kaneka Corporation logo Some data Nov 16, 2026

Kaneka Corporation

KKA · F

Expensive (fair value 32% below the price), but solid company and rising price: meets 2 of 3 rules.

Follow free in the weekly email
Rising price (uptrend) 
Low debt 
Ranks above peers (8/13) 
Quality 54/100 
Mixed Growth (revenue 3y +2.4 %/yr in JPY) 
Thin margins · 4.0% net margin (TTM) 
2.9% dividend yield · Watch coverage
Some data 
Fair value €24.64 · Overvalued 
Negative free cash flow 
Narrow moat 35/100 · thin data
⟳ CyclicalPrice via web search⚠ Thinly traded
Watch Kaneka Corporation for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€36.74 €18.26 Fair Value €24.64 Sep 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

60‑month range €18.26 – €36.74 · fair‑value band €19.87 – €36.14 · the €36.13 price screens above the €24.64 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow Kaneka in your weekly email

Every Wednesday you see whether Kaneka is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Kaneka Corporation engages in the manufacture and sale of polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan, Asia, North America, Europe, and internationally.

Show moreShow less

It offers impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymer, engineering resin for injection molding, acrylic film, and isobutylene-based thermoplastic elastomer products.

The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products.

In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; and organic EL lighting panels, lithium-ion battery, and biosurfactant.

Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad.

Additionally, it provides dairy products, yogurt, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, which include coenzyme, probiotics, and dietary ingredients, as well as fertilizers.

The company was incorporated in 1949 and is headquartered in Tokyo, Japan.

Stock analysis

Kaneka Corporation (KKA) currently trades at €36.13, while our model-based Fair Value estimate is €24.64, 32% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of €50.28 per share, and 7 of the 16 models we run sit above the €36.13 price.

Bear case: the DCF Models group reads lowest at €17.01, and 9 of the 16 models stay below the price. Data coverage for this calculation is medium.

Scenario range: €19.87 (bear) to €36.14 (bull), the price of €36.13 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 54/100 (solid quality), in the Basic Materials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Kaneka Corporation reported revenue of ¥812B in FY2026 versus ¥692B in FY2022, a compound +4.1%/yr. Reported net income was ¥31.0B in FY2026, compounding +4.0%/yr from FY2022.

Key figures

Market cap €2.2B Mid · P/E ratio 11.7 · P/S ratio 0.44 · EPS (TTM) €3.10 · Dividend yield 2.9% · Net margin 3.8% · Return on equity 7.1% · Return on assets (EBIT) 4.4% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 35 out of 100 (low confidence).

What moves the price

The share trades about 1% above its previous 52-week high, currently above its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −44% fair-value upside, at −32%, KKA screens cheaper than that median.

Fair Value models

Bear €19.87 Fair Value €24.64 Bull €36.14
Price €36.13 · Downside -31.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (€1.97 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Owner Earnings €11.22 €17.01 €25.15 76
Residual Income €38.00 €39.28 €42.42 76
EPV €19.94 €23.59 €26.77 74
All 16 models by family
DCF Models
Owner Earnings €11.22 €17.01 €25.15 76
Earnings-Based
Graham-Dodd €20.11 €46.32 €59.45 65
PEG = 1.0 €15.90 €22.71 €29.52 57
EPV €19.94 €23.59 €26.77 74
Dividend Discount
Gordon GGM €14.84 €24.74 €36.28 67
DDM Multi-Stage €14.84 €21.76 €29.36 67
Multiples
P/E Multiple €37.71 €50.28 €62.84 63
P/S Multiple €37.71 €50.28 €62.84 58
P/B Multiple €100.16 €133.54 €166.93 55
EV/EBIT €17.45 €28.44 €39.43 64
EV/EBITDA €41.99 €61.16 €80.33 67
EV/Revenue €13.05 €25.30 €37.55 51
Asset-Based
NCAV (Graham) €0.3800 €0.5700 €0.7100 55
Economic Profit
Residual Income €38.00 €39.28 €42.42 76
ROIC Compounder €19.94 €23.59 €26.77 72
Growth Earnings
Growth-Adj P/E €28.82 €41.18 €53.53 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 54/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 39
How much profit the company makes from its sales and capital
Quality Growth 44
Are margins and returns getting better?
Cashflow 30
Do the profits arrive as real cash?
Financial strength 52
Debt, balance sheet and risk of trouble
Investment 70
Does it invest with discipline instead of growing at any price?
Low Volatility 66
How calm the share price moves, does not count
Price momentum 79
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 98
Distance to the 52-week high, does not count
New shares 100
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 23/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+0.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.4%
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.7%
What shareholders gained per year (last 5 years), in JPY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in JPY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−1.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−3.9%
Dividend (yield on the price)2.9%
Profit margin 2022 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 4%

KKA screens overvalued: fair value 32% below the price. Compare with Linde plc →

Compare Kaneka Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 758 stocks

Beats the industry median on 8/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 54 · Above median
Fair Value upside −31.8% · Below median
Profitability
Return on equity (12 months) 7.1% · Above median
Return on assets 3.2% · Above median
Net margin (12 months) 4.0% · Below median
Operating margin (12 months) 5.3% · Below median
Growth and dividend
Revenue growth (quarter YoY) 12.7% · Below median
Dividend yield (12 months) 2.9% · Above median
Balance sheet
Debt / equity 0.15× · Above median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/E (12 months) 11.7× · Cheapest 25%
P/B 0.76× · Cheapest 25%
P/S (12 months) 0.44× · Cheapest 25%
EV/EBITDA 4.2× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 7
FUTURE (revenue growth)64 · sector 70
PAST (return on equity)28 · sector 26
HEALTH (low debt)93 · sector 95
DIVIDEND (yield)58 · sector 31

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wanhua Chemical Group 600309 ¥69.18 ¥68.03 −2% vs KKA
Linde plc LIN $515.11 $446.62 −13% vs KKA
PPG Industries, Inc PPG $120.82 $77.68 −36% vs KKA
DSM-Firmenich AG DSFIR CHF 96.00 CHF 58.32 −39% vs KKA
Asian Paints Limited ASIANPAINT ₹2,625 ₹1,479 −44% vs KKA
The Sherwin-Williams Company SHW $344.15 $152.59 −56% vs KKA
Givaudan SA GIVN CHF 4,072 CHF 1,618 −60% vs KKA
EMS-CHEMIE HOLDING AG EMSN CHF 836.00 CHF 284.63 −66% vs KKA
Ecolab Inc ECL $302.59 $97.18 −68% vs KKA
Air Products and Chemicals, Inc APD $306.92 $75.33 −75% vs KKA

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Kaneka Corporation: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Kaneka Corporation Fair Value". https://www.fairvalue-calculator.com/stock/KKA

Frequently asked questions

Is Kaneka Corporation (KKA) overvalued or undervalued?
As of Nov 16, 2026, our model estimates a fair value of €24.64 versus a price of €36.13, about 32% lower (overvalued).
What is the fair value of KKA?
Our model-based fair value for Kaneka Corporation is €24.64 (as of Nov 16, 2026), built from audited fundamentals. The current price: €36.13.
What is the quality score of KKA?
Kaneka Corporation has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kaneka Corporation (KKA)?
Our model-based price target is the fair value of €24.64 (as of Nov 16, 2026) from 16 valuation models. Cautious scenario €19.87, optimistic scenario €36.14. It is a calculation from audited fundamentals, not an analyst target.
What is the Kaneka Corporation stock forecast for 2026?
Our models put fair value at €24.64, about 32% lower versus a price of €36.13 (overvalued). Cautious scenario €19.87, optimistic scenario €36.14. The calculation is refreshed regularly with new filings.
What is the revenue of Kaneka Corporation (KKA)?
Kaneka Corporation reported trailing-twelve-month revenue of about ¥861B (latest available figure, as of Nov 16, 2026).
Does Kaneka Corporation pay a dividend?
Kaneka Corporation currently shows a dividend yield of 2.89% relative to its recent price (as of Nov 16, 2026).
How much is the dividend of Kaneka Corporation (KKA) and when is the ex-dividend date?
Kaneka Corporation has a dividend yield of 2.9%. The next ex-dividend date is Mar 30, 2027. A dividend has been paid every year since at least 2010. The payout ratio is 35.2% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Kaneka Corporation (KKA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kaneka Corporation it is €24.64 per share (as of Nov 16, 2026), against a price of €36.13. It is the blended result of 16 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Kaneka Corporation stock overvalued or undervalued in 2026?
As of Nov 16, 2026, KKA trades above its calculated fair value: price €36.13, fair value €24.64, a gap of about −32% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of KKA?
No. The price is what the market pays today (€36.13); the fair value is what the company's own numbers justify (€24.64). For Kaneka Corporation the two are €11.49 per share apart. That gap is exactly why we show both numbers side by side.
How much is Kaneka Corporation worth?
The market values Kaneka Corporation at about €2.2B (market capitalisation, as of Nov 16, 2026). Per share that is €36.13; our models calculate a fair value of €24.64 per share.
What do the bullish and bearish scenarios say about KKA?
Our models span a range for Kaneka Corporation: cautious scenario €19.87, base €24.64, optimistic €36.14 per share (as of Nov 16, 2026, price €36.13). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of KKA?
Kaneka Corporation trades at a price-to-earnings ratio of 11.7 (as of Nov 16, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €24.64 is built from several models across several years. Other multiples: P/B 0.8, P/S 0.4, EV/EBITDA 4.2.
How solid is the balance sheet of Kaneka Corporation (KKA)?
Balance-sheet figures for Kaneka Corporation (as of Nov 16, 2026): return on equity 7.1%, debt of 0.15 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is KKA from its 52-week high?
Kaneka Corporation trades at €36.13, about 1% above its previous 52-week high of €35.80 and 75% above the low of €20.65 (as of Nov 17, 2026). Distance from the high says nothing about value: that is what the fair value of €24.64 is for.
Which stocks are comparable to Kaneka Corporation?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kaneka Corporation stock attractive at the current price?
The data as of Nov 16, 2026: price €36.13, calculated fair value €24.64 (−32%), Quality Score 54/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of KKA calculated?
We run Kaneka Corporation through 16 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of €24.64 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3% above its aggregate fair value. Kaneka Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kaneka Corporation (KKA)?
The closing price on Nov 17, 2026 was €36.13. Our model-based fair value is €24.64, about 32% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kaneka Corporation right now?
Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (€19.87 to €36.14) leaves room in how you read the outcome.

Key figures of Kaneka Corporation

How large is the market capitalisation of Kaneka Corporation (KKA)?
The market capitalisation of Kaneka Corporation is €2.2B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kaneka Corporation (KKA)?
The price-to-sales ratio of Kaneka Corporation is 0.44 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Kaneka Corporation (KKA)?
Earnings per share at Kaneka Corporation are €3.10 (price ÷ EPS = P/E 11.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Kaneka Corporation (KKA)?
The dividend yield of Kaneka Corporation is 2.9% (payout 33.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Kaneka Corporation (KKA)?
The net margin of Kaneka Corporation is 3.8% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kaneka Corporation (KKA)?
The return on equity (ROE) of Kaneka Corporation is 7.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kaneka Corporation (KKA)?
On an EBIT basis the return on assets of Kaneka Corporation is 4.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kaneka Corporation (KKA)?
The operating margin of Kaneka Corporation is 5.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kaneka Corporation (KKA)?
Revenue at Kaneka Corporation is growing 12.7% versus a year earlier (3y avg +2.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Kaneka Corporation (KKA)?
Earnings per share at Kaneka Corporation are down 12.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Kaneka Corporation (KKA) generate?
The free cash flow of Kaneka Corporation is −¥3.3B (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Kaneka Corporation (KKA) carry?
The net debt of Kaneka Corporation is ¥163B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Kaneka Corporation in the live analysis

One click puts Kaneka Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.